Valine

Valine

SCHEMBL826319

CC(C)[C@H](N)C(=O)O.O=C(CCl)c1ccc2oc(=O)[nH]c2c1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
KDM4E B2RXH2 1/20 0.58
NOS1 P29475 4/20 0.41
NOS3 P29474 3/20 0.41
NOS2 P35228 3/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
ADRA2A P08913 1/20 0.41
TSHR P16473 1/20 0.41
THPO P40225 1/20 0.41
BLM P54132 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CREBBP Q92793 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
POLB P06746 1/20 0.37
SMYD3 Q9H7B4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL823908 0.85 ALDH1A1 (0.78) ALDH1A1KDM4ENOS1NOS3NOS2
SCHEMBL172191 0.75 ALDH1A1 (1.00) ALDH1A1KDM4ENOS1NOS3NOS2
SCHEMBL25139890 0.75 KDM4E (0.56) ALDH1A1KDM4ENOS1NOS3NOS2
SCHEMBL25139959 0.72 NOS1 (0.54) ALDH1A1KDM4ENOS1NOS3NOS2
SCHEMBL19513027 0.72 KDM4E (0.56) ALDH1A1KDM4ENOS1NOS3NOS2
Phenacyl Chloride SCHEMBL8429323 0.72 ALDH1A1 (0.63) ALDH1A1KDM4ELMNATSHRNPSR1
SCHEMBL1421351 0.71 NOS1 (0.56) ALDH1A1KDM4ENOS1NOS3NOS2
SCHEMBL4286466 0.70 KDM4E (0.51) ALDH1A1KDM4ENOS1NOS3NOS2
SCHEMBL1119326 0.70 NOS1 (0.59) ALDH1A1KDM4ENOS1NOS3NOS2
SCHEMBL2315044 0.70 NOS1 (0.59) ALDH1A1KDM4ENOS1NOS3NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143296-B2 Thiazole-based compound and inhibitor of T-type calcium channel containing the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2012-03-27 US disclosed
US-20100179201-A1 NOVEL THIAZOLE-BASED COMPOUND AND INHIBITOR OF T-TYPE CALCIUM CHANNEL CONTAINING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-07-15 US disclosed
WO-2008018655-A1 NOVEL THIAZOLE-BASED COMPOUND AND INHIBITOR OF T-TYPE CALCIUM CHANNEL CONTAINING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179201-A1 NOVEL THIAZOLE-BASED COMPOUND AND INHIBITOR OF T-TYPE CALCIUM CHANNEL CONTAINING THE SAME CACNA1G, CACNA1I, CACNA1H ALDH1A1 4316/4885KDM4E 3816/4885NOS1 4259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.